BioLife Solutions Inc (BLFS)
Debt-to-capital ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 18,311 | 20,937 | 23,572 | 23,692 | 23,793 | 24,207 | 6,188 | 6,313 | 6,353 | 6,122 | 5,019 | 916 | 655 | — | — | — | — | — | — | — |
Total stockholders’ equity | US$ in thousands | 337,663 | 332,017 | 352,128 | 358,107 | 364,188 | 405,120 | 409,544 | 476,075 | 478,047 | 489,259 | 452,281 | 208,777 | 204,429 | 186,851 | 105,843 | 67,709 | 43,321 | 35,191 | 2,072 | -3,740 |
Debt-to-capital ratio | 0.05 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $18,311K ÷ ($18,311K + $337,663K)
= 0.05
The debt-to-capital ratio of BioLife Solutions Inc has been relatively stable over the past few quarters, hovering between 0.00 and 0.06. This indicates that the company has maintained a conservative approach to financing its operations, with a low level of debt relative to its total capital. The sudden increase from 0.00 in the first quarter of 2022 to 0.06 in the second quarter of 2022 could be a result of a significant change in the capital structure, possibly due to new debt issuance or a decrease in equity. However, the ratio quickly decreased back to 0.01 in subsequent quarters, suggesting a return to the previous capital structure. Overall, the consistent low debt-to-capital ratio reflects a financially healthy position for BioLife Solutions Inc, indicating lower financial risk and a stable foundation for future growth.
Peer comparison
Dec 31, 2023